Matches in SemOpenAlex for { <https://semopenalex.org/work/W4365138616> ?p ?o ?g. }
- W4365138616 abstract "Abstract Parkinso’s disease (PD) is a common neurodegenerative movement disorder and leucine-rich repeat kinase 2 (LRRK2) is a promising therapeutic target for disease intervention. However, the ability to stratify patients who will benefit from such treatment modalities based on shared etiology is critical for the success of disease-modifying therapies. Ciliary and centrosomal alterations are commonly associated with pathogenic LRRK2 kinase activity and can be detected in many cell types. We previously found centrosomal deficits in immortalized lymphocytes from G2019S-LRRK2 PD patients. Here, to investigate whether such deficits may serve as a potential blood biomarker for PD which is susceptible to LRKK2 inhibitor treatment, we characterized patient-derived cells from distinct PD cohorts. We report centrosomal alterations in peripheral cells from a subset of early-stage idiopathic PD patients which is mitigated by LRRK2 kinase inhibition, supporting a role for aberrant LRRK2 activity in idiopathic PD. Centrosomal defects are detected in R1441G-LRRK2 and G2019S-LRRK2 PD patients and in non-manifesting LRRK2 mutation carriers, indicating that they acumulate prior to a clinical PD diagnosis. They are present in immortalized cells as well as in primary lymphocytes from peripheral blood. These findings indicate that analysis of centrosomal defects as a blood-based patient stratification biomarker may help nominate PD patients who will benefit from LRRK2-related therapeutics. One-sentence summary Peripheral blood-derived cells can be employed to stratify Parkinso’s disease patients most likely to respond to LRRK2-related therapeutics." @default.
- W4365138616 created "2023-04-13" @default.
- W4365138616 creator A5006772929 @default.
- W4365138616 creator A5008182071 @default.
- W4365138616 creator A5012244709 @default.
- W4365138616 creator A5015133218 @default.
- W4365138616 creator A5015247251 @default.
- W4365138616 creator A5015643840 @default.
- W4365138616 creator A5019422306 @default.
- W4365138616 creator A5022990900 @default.
- W4365138616 creator A5030261402 @default.
- W4365138616 creator A5037464931 @default.
- W4365138616 creator A5045269545 @default.
- W4365138616 creator A5045559041 @default.
- W4365138616 creator A5045959178 @default.
- W4365138616 creator A5047141421 @default.
- W4365138616 creator A5047969316 @default.
- W4365138616 creator A5049407916 @default.
- W4365138616 creator A5053724696 @default.
- W4365138616 creator A5058098329 @default.
- W4365138616 creator A5063147284 @default.
- W4365138616 creator A5074741395 @default.
- W4365138616 creator A5082957589 @default.
- W4365138616 creator A5083440007 @default.
- W4365138616 creator A5087085858 @default.
- W4365138616 creator A5090189628 @default.
- W4365138616 date "2023-04-12" @default.
- W4365138616 modified "2023-10-17" @default.
- W4365138616 title "A potential patient stratification biomarker for Parkinso’s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells" @default.
- W4365138616 cites W1967659552 @default.
- W4365138616 cites W2023025710 @default.
- W4365138616 cites W2026977699 @default.
- W4365138616 cites W2028617035 @default.
- W4365138616 cites W2059578012 @default.
- W4365138616 cites W2059681460 @default.
- W4365138616 cites W2061536528 @default.
- W4365138616 cites W2075775411 @default.
- W4365138616 cites W2093376914 @default.
- W4365138616 cites W2104406175 @default.
- W4365138616 cites W2113824125 @default.
- W4365138616 cites W2121346405 @default.
- W4365138616 cites W2132549333 @default.
- W4365138616 cites W2134829539 @default.
- W4365138616 cites W2139684689 @default.
- W4365138616 cites W2141459724 @default.
- W4365138616 cites W2148641246 @default.
- W4365138616 cites W2167756140 @default.
- W4365138616 cites W2170829331 @default.
- W4365138616 cites W2253950023 @default.
- W4365138616 cites W2295939659 @default.
- W4365138616 cites W2435254117 @default.
- W4365138616 cites W2515462698 @default.
- W4365138616 cites W2749429999 @default.
- W4365138616 cites W2767503875 @default.
- W4365138616 cites W2768016303 @default.
- W4365138616 cites W2773134245 @default.
- W4365138616 cites W2794912227 @default.
- W4365138616 cites W2802214895 @default.
- W4365138616 cites W2802569747 @default.
- W4365138616 cites W2883053634 @default.
- W4365138616 cites W2893461341 @default.
- W4365138616 cites W2899593101 @default.
- W4365138616 cites W2907261559 @default.
- W4365138616 cites W2912069022 @default.
- W4365138616 cites W2917327135 @default.
- W4365138616 cites W2920406131 @default.
- W4365138616 cites W2945356154 @default.
- W4365138616 cites W2969456175 @default.
- W4365138616 cites W2972588477 @default.
- W4365138616 cites W2973557301 @default.
- W4365138616 cites W3003392730 @default.
- W4365138616 cites W3011557986 @default.
- W4365138616 cites W3016100309 @default.
- W4365138616 cites W3036819741 @default.
- W4365138616 cites W3039492798 @default.
- W4365138616 cites W3040983129 @default.
- W4365138616 cites W3041462171 @default.
- W4365138616 cites W3066194956 @default.
- W4365138616 cites W3090572476 @default.
- W4365138616 cites W3093253626 @default.
- W4365138616 cites W3095796072 @default.
- W4365138616 cites W3098923693 @default.
- W4365138616 cites W3100227119 @default.
- W4365138616 cites W3121728483 @default.
- W4365138616 cites W3123692160 @default.
- W4365138616 cites W3136908976 @default.
- W4365138616 cites W3158748733 @default.
- W4365138616 cites W3166052330 @default.
- W4365138616 cites W3169685488 @default.
- W4365138616 cites W3173661759 @default.
- W4365138616 cites W3177698793 @default.
- W4365138616 cites W3205174301 @default.
- W4365138616 cites W4206114996 @default.
- W4365138616 cites W4206394272 @default.
- W4365138616 cites W4210841259 @default.
- W4365138616 cites W4211219399 @default.
- W4365138616 cites W4220817279 @default.
- W4365138616 cites W4280593294 @default.
- W4365138616 cites W4280596427 @default.
- W4365138616 cites W4281608896 @default.